口服对比剂FDG PET/CT揭示淋巴瘤患者肠膀胱瘘
一名60岁男性结肠弥漫性大B细胞淋巴瘤患者,初分期行FDG PET/CT检查,临床疑似肠膀胱瘘。口服对比剂后,大量对比剂积聚于肠腔并经清晰标记的瘘管漏入膀胱,相应瘘管处FDG摄取呈线状从膀胱延伸至结肠腔,病灶内SUVmax与膀胱相当。膀胱造影证实肠膀胱瘘存在。
要点
- 口服对比剂后FDG PET/CT可显示对比剂经瘘管从肠腔漏入膀胱。
- 瘘管处FDG摄取呈线状,从膀胱延伸至结肠腔,SUVmax与膀胱相当。
- 膀胱造影证实了肠膀胱瘘的存在。
核心结论
- 口服对比剂FDG PET/CT可显示淋巴瘤患者的肠膀胱瘘,表现为对比剂漏入膀胱及瘘管处线状FDG摄取。
研究设计与样本
- 病例报告:一名60岁男性结肠弥漫性大B细胞淋巴瘤患者,初分期行FDG PET/CT检查。
主要发现
- 口服对比剂后,大量对比剂积聚在肠腔并经清晰标记的瘘管漏入膀胱。
- 对应瘘管处,FDG摄取呈线状从膀胱延伸至结肠腔,病灶内测得SUVmax与膀胱相当。
- 膀胱造影证实肠膀胱瘘存在。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
A 60-year-old man with colonic diffuse large B-cell lymphoma was referred for FDG PET/CT for initial staging. He was suspected of enterovesical fistula. After oral administration, large amounts of contrast agents accumulated in the bowel lumen and leaked into the bladder through a well-marked fistulous tract. Corresponding to the fistula, a linear pattern of FDG uptake extended from the bladder into the colonic lumen, and the measured SUV max inside the lesion was as high as that of the urinary bladder. Cystography confirmed the presence of the enterovesical fistula.
引用
- Guo L, Shen G. Enterovesical Fistula in a Lymphoma Patient Revealed by FDG PET/CT With an Oral Contrast Agents. Clin Nucl Med. 2023. PMID: 37976526. doi:10.1097/RLU.0000000000004954
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。